Skip to main content
OFIX logo

Orthofix Medical Inc.

OFIXNASDAQHealthcareMedical Devices

$9.40Today:- (-)1Y −36.32%

As of Oct 16, 2026 close

Market cap
$392.29M
P/E (TTM)
-
Forward P/E
-
Dividend yield
-
52-week range
$8.50$16.99
Volume (live)
-
Avg. volume (3M)
408.62K

Orthofix Medical (OFIX) Cash Flow Statement

In fiscal 2025 (fiscal year ended Dec 31, 2025), Orthofix Medical generated $33.35M of operating cash flow and spent $34.63M on capital expenditures. That left free cash flow of −$1.28M.

Orthofix Medical Cash Flow Statement Analysis

Values in millions USD

Scroll to see more
Cash flow statement showing operating, investing, and financing activities for Orthofix Medical Inc. (OFIX) - Annual data in millions USD
BreakdownFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017
Period endingDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017
Operating Activities
Net Income-92.19-126.00-151.40-19.75-38.382.52-28.4613.816.22
Depreciation & Amortization83.2675.9660.5632.0833.1034.2824.7018.6620.12
Deferred Income Tax0.221.880.580.3124.4810.791.39-2.6621.29
Stock Based Compensation28.6932.4635.7118.4415.4316.2121.5418.9312.56
Change in Working Capital-20.16-19.25-53.96-29.24-18.1019.70-29.38-7.00-17.18
Change in Accounts Receivable-1.58-9.53-10.41-6.74-7.0513.28-11.04-3.71-6.56
Change in Inventory-10.75-5.55-58.05-18.130.62-0.87-5.719.70-15.65
Change in Accounts Payable2.60-5.578.642.284.252.532.14-0.172.32
Change in Other Working Capital-0.691.3932.06-6.65-15.934.76-14.77-12.822.70
Other Operating Activities-0.6960.7432.06-13.391.95-9.2142.248.1810.33
Net Cash from Operating Activities33.3525.79-45.75-11.5418.4874.2732.0349.9253.34
Investing Activities
Capital Expenditures-34.63-34.88-62.05-23.16-19.59-17.09-20.52-15.26-16.95
Acquisitions0.000.0029.42-1.500.00-18.000.00-44.290.00
Purchases of Investments0.000.000.000.00-2.17-10.000.000.000.00
Sales/Maturities of Investments0.007.400.000.130.0017.090.000.000.00
Other Investing Activities0.03-0.10-0.500.00-1.25-24.33-2.40-1.450.47
Net Cash from Investing Activities-34.60-27.58-33.13-24.53-23.01-52.33-22.92-61.00-16.47
Financing Activities
Debt Repayment-0.7654.39-106.55-2.59-0.54-0.32-0.370.000.00
Common Stock Issued5.936.265.134.348.827.6011.557.107.78
Common Stock Repurchased0.000.00-4.400.000.000.000.000.000.00
Other Financing Activities-5.95-9.94-7.75-1.82-11.91-4.03-21.87-4.11-4.25
Net Cash from Financing Activities-0.7950.7165.32-0.08-3.623.25-10.692.993.54
Summary
Effect of Forex Changes on Cash1.41-0.940.62-1.00-0.821.24-0.21-0.881.18
Net Change in Cash-0.6247.98-12.94-37.15-8.9726.42-1.79-8.9741.59
Cash at Beginning of Period85.7437.7650.7087.8596.8270.4072.1981.1639.57
Cash at End of Period85.1285.7437.7650.7087.8596.8270.4072.1981.16
Free Cash Flow-1.28-9.09-107.80-34.70-1.1257.1811.5134.6636.39
Supplemental Disclosures
Interest Paid-16.905.801.401.501.90---
Income Taxes Paid-1.300.90-0.904.800.50---

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About Orthofix Medical Cash Flow

What is Orthofix Medical's free cash flow?

Orthofix Medical had negative free cash flow of $1.28M in fiscal 2025 (fiscal year ended Dec 31, 2025), operating cash flow of $33.35M minus $34.63M of capital expenditures.

How much does Orthofix Medical spend on capital expenditures?

Orthofix Medical spent $34.63M on capital expenditures in fiscal 2025, compared with $34.88M a year earlier. That equals 103.8% of operating cash flow.

Does Orthofix Medical pay dividends or buy back shares?

Orthofix Medical's cash flow statement for fiscal 2025 shows no dividend payments or share repurchases.

What is free cash flow?

Free cash flow is operating cash flow minus capital expenditures. It is the cash a company has left for dividends, buybacks, debt repayment or acquisitions after funding its operations and investment. Full definition